Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -
Status:
Recruiting
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
A study on patients who are hospitalized and tested positive for COVID-19 or have a typical
CT image of COVID-19 infection, to establish if omega-3 Polyunsaturated Fatty Acid (PUFA)
supplementation by intravenous route is a possible treatment option in COVID-19 with minimal
risks to the patients.